HK1 and cancer: The fact that kallistatin, which rapidly binds hK1 and inhibits its activity in vitro (Zhou et al, 1992), blocks the strengthening action of GIST882 cells on HUVEC networks argues in favour of hK1 as a promoter of cancer angiogenesis.